{"id":27777,"date":"2026-01-23T08:29:55","date_gmt":"2026-01-23T07:29:55","guid":{"rendered":"https:\/\/piumedical.com\/?page_id=27777"},"modified":"2026-02-19T16:08:53","modified_gmt":"2026-02-19T15:08:53","slug":"significant-shareholders-3","status":"publish","type":"page","link":"https:\/\/piumedical.com\/en\/significant-shareholders-3\/","title":{"rendered":"Significant shareholders"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"27777\" class=\"elementor elementor-27777\">\n\t\t\t\t        <section class=\"elementor-section elementor-top-section elementor-element elementor-element-47bc698 elementor-section-stretched elementor-section-boxed elementor-section-height-default elementor-section-height-default pxl-row-scroll-none pxl-zoom-point-false pxl-section-overflow-visible pxl-section-fix-none pxl_parallax_bg_img_noise-none pxl-bg-color-none pxl-section-overlay-none wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no\" data-id=\"47bc698\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;}\">\n\n                \n                <div class=\"elementor-container elementor-column-gap-extended \">\n                <div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-70be587 pxl-column-none pxl-column-overflow-hidden-no pxl-column-zoom-no\" data-id=\"70be587\" data-element_type=\"column\" data-e-type=\"column\">\r\n        <div class=\"elementor-widget-wrap elementor-element-populated\">\r\n                     \r\n        \t\t<div class=\"elementor-element elementor-element-95f56db elementor-widget elementor-widget-pxl_heading\" data-id=\"95f56db\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"pxl_heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\n<div id=\"pxl-pxl_heading-95f56db-7450\" class=\"pxl-heading px-sub-title-default style-default-style \">\n\t<div class=\"pxl-heading--inner\">\n\t\t\n\t\t<h3 class=\"pxl-item--title pxl-split-text style-default  highlight-default split-words-scale \" data-wow-delay=\"ms\">\n\t\t\t\t\tSignificant Shareholders\t\n\t\t\t\n\t\t<\/h3>\n\n\t<\/div>\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t            <\/div>\r\n        <\/div>\r\n        \t\t\t<\/div>\n\t\t<\/section>\n\t\t        <section class=\"elementor-section elementor-top-section elementor-element elementor-element-eeec76c elementor-section-stretched elementor-section-boxed elementor-section-height-default elementor-section-height-default pxl-row-scroll-none pxl-zoom-point-false pxl-section-overflow-visible pxl-section-fix-none pxl_parallax_bg_img_noise-none pxl-bg-color-none pxl-section-overlay-none wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no\" data-id=\"eeec76c\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;}\">\n\n                \n                <div class=\"elementor-container elementor-column-gap-extended \">\n                <div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b65b61a pxl-column-none pxl-column-overflow-hidden-no pxl-column-zoom-no\" data-id=\"b65b61a\" data-element_type=\"column\" data-e-type=\"column\">\r\n        <div class=\"elementor-widget-wrap elementor-element-populated\">\r\n                     \r\n        \t\t<div class=\"elementor-element elementor-element-9891272 elementor-widget elementor-widget-text-editor\" data-id=\"9891272\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><style><span data-mce-type=\"bookmark\" style=\"display: inline-block; width: 0px; overflow: hidden; line-height: 0;\" class=\"mce_SELRES_start\"><\/span><br> .tabella-azionisti {<br> width: 100%;<br> border-collapse: collapse;<br> text-align: center; \/* tutte le celle al centro... *\/<br> }<\/p>\n<p> .tabella-azionisti th,<br>.tabella-azionisti td {<br>padding: 6px 10px;<br>}<\/p>\n<p> .tabella-azionisti th:first-child,<br>.tabella-azionisti td:first-child {<br>text-align: left; \/* ...tranne la prima colonna *\/<br>}<br><\/style><\/p><p>%<\/p><table class=\"tabella-azionisti\"><thead><tr><th>Shareholder<\/th><th>No. of Ordinary Shares<\/th><th>No. of Multiple-Vote<\/th><th>Shares % of Share Capital<\/th><th>of Voting Rights<\/th><\/tr><\/thead><tbody><tr><td>G.S.M. S.r.l.<\/td><td>3.115.228<\/td><td>259.881<\/td><td>50,37%<\/td><td>58,01%<\/td><\/tr><tr><td>La Farmaceutica S.p.A.<\/td><td>1.080.272<\/td><td>90.119<\/td><td>17,47%<\/td><td>20,12%<\/td><\/tr><tr><td>First SICAF S.p.A.<\/td><td>800.000<\/td><td>&#8211;<\/td><td>11,94%<\/td><td>8,12%<\/td><\/tr><tr><td>Mercato<\/td><td>1.354.500<\/td><td>&#8211;<\/td><td>20,22%<\/td><td>13,75%<\/td><\/tr><\/tbody><tfoot><tr><th>Totale<\/th><th>6.350.000<\/th><th>350.000<\/th><th>100,00%<\/th><th>100,00%<\/th><\/tr><\/tfoot><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b90bdcc elementor-widget elementor-widget-text-editor\" data-id=\"b90bdcc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p style=\"font-weight: 400;\">Pursuant to the Euronext Growth Milan Issuers\u2019 Regulation, shareholders who hold an interest in the share capital of Pi\u00f9 Medical S.p.A. (the \u201cIssuer\u201d) are required to notify the Issuer of any \u201cmaterial change\u201d, i.e., the reaching or exceeding of the thresholds of 5%, 10%, 15%, 20%, 25%, 30%, 50%, 66.6% and 90% of the Issuer\u2019s share capital, as well as any decrease below the above thresholds (the \u201cMaterial Change\u201d). For the purposes of these disclosure obligations, \u201cshare capital\u201d means both the total number of voting rights and the number of ordinary shares held, and both notifications are required.<\/p>\n<p style=\"font-weight: 400;\">For the purposes of calculating the holdings of a so-called significant shareholder\u2014i.e., a shareholder who holds 5% or more of a class of shares admitted to trading on Euronext Growth Milan (excluding treasury shares), pursuant to the major shareholdings regime under the Italian Consolidated Law on Finance (Testo Unico della Finanza)\u2014the following must be taken into account: (i) the shareholdings held by the shareholder (even if the voting rights are exercised by or attributed to third parties); (ii) the shareholdings in respect of which voting rights are exercised by or attributed to the shareholder; (iii) the shares held by nominees, fiduciaries, controlled companies, or in respect of which voting rights are exercised by or attributed to such persons; and (iv) the shares collectively contributed under a shareholders\u2019 agreement concerning the exercise of voting rights in the Issuer.<\/p>\n<p style=\"font-weight: 400;\">For the purposes of the above, promptly and in any event within four trading days of the transaction that triggers the obligation (regardless of the settlement date) or of the day on which the significant shareholder becomes aware of events resulting in changes to the Issuer\u2019s share capital, the significant shareholder must notify the Issuer of:<\/p>\n<ul>\n<li style=\"font-weight: 400;\">its identity<\/li>\n<li style=\"font-weight: 400;\">the date on which the Issuer was notified;<\/li>\n<li style=\"font-weight: 400;\">the date on which the Material Change in the shareholding occurred;<\/li>\n<li style=\"font-weight: 400;\">the nature and size of the significant shareholder\u2019s interest in the transaction (in the event of the issuance of multiple-vote shares, the number of voting rights and the number of ordinary shares held).<\/li>\n<\/ul>\n<p style=\"font-weight: 400;\">The notice must be sent via certified email (PEC) to the following address: <a href=\"mailto:investorrelations@pi%C3%B9medical.com\" data-ogsc=\"\" data-outlook-id=\"8c82e92a-580a-4583-b25f-a6adb37a6590\">investorrelations@piumedical.com<\/a> and, for information.<\/p>\n<p>Download HERE the form for reporting substantial changes in shareholdings.<\/p>\n<p style=\"font-weight: 400;\">purposes, to <a href=\"mailto:piumedical@legalmail.it\" data-ogsc=\"\" data-outlook-id=\"276bb2f4-3351-4b9d-aa1a-b1a43e4d4c0e\">piumedical@legalmail.it<\/a><\/p>\n<p class=\"MsoNormal\"><span style=\"font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman';\">Download&nbsp;<\/span><a href=\"https:\/\/piumedical.com\/wp-content\/uploads\/Modulo-comunicazione-azionista-significativo-Template3216783851.1-1.pdf\" target=\"_blank\">HERE&nbsp;<\/a><span style=\"font-size: 10.5pt; mso-fareast-font-family: 'Times New Roman';\">the form for reporting substantial changes in shareholdings.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t            <\/div>\r\n        <\/div>\r\n        \t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Significant Shareholders % Shareholder No. of Ordinary Shares No. of Multiple-Vote Shares % of Share Capital of Voting Rights G.S.M. S.r.l. 3.115.228 259.881 50,37% 58,01% La Farmaceutica S.p.A. 1.080.272 90.119 17,47% 20,12% First SICAF S.p.A. 800.000 &#8211; 11,94% 8,12% Mercato 1.354.500 &#8211; 20,22% 13,75% Totale 6.350.000 350.000 100,00% 100,00% Pursuant to the Euronext Growth Milan Issuers\u2019 Regulation, shareholders who hold an interest in the share capital of Pi\u00f9 Medical S.p.A. (the \u201cIssuer\u201d) are required to notify the Issuer of any \u201cmaterial change\u201d, i.e., the reaching or exceeding of the thresholds of 5%, 10%, 15%, 20%, 25%, 30%, 50%, 66.6% and 90% of the Issuer\u2019s share capital, as well as any decrease below the above thresholds (the \u201cMaterial Change\u201d). For the purposes of these disclosure obligations, \u201cshare capital\u201d means both the total number of voting rights and the number of ordinary shares held, and both notifications are required. For the purposes of calculating the holdings of a so-called significant shareholder\u2014i.e., a shareholder who holds 5% or more of a class of shares admitted to trading on Euronext Growth Milan (excluding treasury shares), pursuant to the major shareholdings regime under the Italian Consolidated Law on Finance (Testo Unico della Finanza)\u2014the following must be taken into account: (i) the shareholdings held by the shareholder (even if the voting rights are exercised by or attributed to third parties); (ii) the shareholdings in respect of which voting rights are exercised by or attributed to the shareholder; (iii) the shares held by nominees, fiduciaries, controlled companies, or in respect of which voting rights are exercised by or attributed to such persons; and (iv) the shares collectively contributed under a shareholders\u2019 agreement concerning the exercise of voting rights in the Issuer. For the purposes of the above, promptly and in any event within four trading days of the transaction that triggers the obligation (regardless of the settlement date) or of the day on which the significant shareholder becomes aware of events resulting in changes to the Issuer\u2019s share capital, the significant shareholder must notify the Issuer of: its identity the date on which the Issuer was notified; the date on which the Material Change in the shareholding occurred; the nature and size of the significant shareholder\u2019s interest in the transaction (in the event of the issuance of multiple-vote shares, the number of voting rights and the number of ordinary shares held). The notice must be sent via certified email (PEC) to the following address: investorrelations@piumedical.com and, for information. Download HERE the form for reporting substantial changes in shareholdings. purposes, to piumedical@legalmail.it Download&nbsp;HERE&nbsp;the form for reporting substantial changes in shareholdings.<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"content-type":"","footnotes":""},"class_list":["post-27777","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Principali Azionisti e Partecipazioni - Pi\u00f9Medical Spa<\/title>\n<meta name=\"description\" content=\"Scopri gli azionisti significativi di Pi\u00f9Medical. Visualizza le principali partecipazioni e l&#039;elenco degli investitori che contribuiscono al nostro successo e alla crescita continua.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/piumedical.com\/en\/significant-shareholders-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Principali Azionisti e Partecipazioni - Pi\u00f9Medical Spa\" \/>\n<meta property=\"og:description\" content=\"Scopri gli azionisti significativi di Pi\u00f9Medical. Visualizza le principali partecipazioni e l&#039;elenco degli investitori che contribuiscono al nostro successo e alla crescita continua.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/piumedical.com\/en\/significant-shareholders-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Pi\u00f9Medical Spa\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-19T15:08:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/piumedical.com\\\/en\\\/significant-shareholders-3\\\/\",\"url\":\"https:\\\/\\\/piumedical.com\\\/en\\\/significant-shareholders-3\\\/\",\"name\":\"Principali Azionisti e Partecipazioni - Pi\u00f9Medical Spa\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/piumedical.com\\\/en\\\/#website\"},\"datePublished\":\"2026-01-23T07:29:55+00:00\",\"dateModified\":\"2026-02-19T15:08:53+00:00\",\"description\":\"Scopri gli azionisti significativi di Pi\u00f9Medical. Visualizza le principali partecipazioni e l'elenco degli investitori che contribuiscono al nostro successo e alla crescita continua.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/piumedical.com\\\/en\\\/significant-shareholders-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/piumedical.com\\\/en\\\/significant-shareholders-3\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/piumedical.com\\\/en\\\/significant-shareholders-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/piumedical.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Significant shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/piumedical.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/piumedical.com\\\/en\\\/\",\"name\":\"Pi\u00f9Medical Spa\",\"description\":\"Architecture\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/piumedical.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Principali Azionisti e Partecipazioni - Pi\u00f9Medical Spa","description":"Scopri gli azionisti significativi di Pi\u00f9Medical. Visualizza le principali partecipazioni e l'elenco degli investitori che contribuiscono al nostro successo e alla crescita continua.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/piumedical.com\/en\/significant-shareholders-3\/","og_locale":"en_US","og_type":"article","og_title":"Principali Azionisti e Partecipazioni - Pi\u00f9Medical Spa","og_description":"Scopri gli azionisti significativi di Pi\u00f9Medical. Visualizza le principali partecipazioni e l'elenco degli investitori che contribuiscono al nostro successo e alla crescita continua.","og_url":"https:\/\/piumedical.com\/en\/significant-shareholders-3\/","og_site_name":"Pi\u00f9Medical Spa","article_modified_time":"2026-02-19T15:08:53+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/piumedical.com\/en\/significant-shareholders-3\/","url":"https:\/\/piumedical.com\/en\/significant-shareholders-3\/","name":"Principali Azionisti e Partecipazioni - Pi\u00f9Medical Spa","isPartOf":{"@id":"https:\/\/piumedical.com\/en\/#website"},"datePublished":"2026-01-23T07:29:55+00:00","dateModified":"2026-02-19T15:08:53+00:00","description":"Scopri gli azionisti significativi di Pi\u00f9Medical. Visualizza le principali partecipazioni e l'elenco degli investitori che contribuiscono al nostro successo e alla crescita continua.","breadcrumb":{"@id":"https:\/\/piumedical.com\/en\/significant-shareholders-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/piumedical.com\/en\/significant-shareholders-3\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/piumedical.com\/en\/significant-shareholders-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/piumedical.com\/en\/"},{"@type":"ListItem","position":2,"name":"Significant shareholders"}]},{"@type":"WebSite","@id":"https:\/\/piumedical.com\/en\/#website","url":"https:\/\/piumedical.com\/en\/","name":"Pi\u00f9Medical Spa","description":"Architecture","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/piumedical.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/piumedical.com\/en\/wp-json\/wp\/v2\/pages\/27777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piumedical.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/piumedical.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/piumedical.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/piumedical.com\/en\/wp-json\/wp\/v2\/comments?post=27777"}],"version-history":[{"count":7,"href":"https:\/\/piumedical.com\/en\/wp-json\/wp\/v2\/pages\/27777\/revisions"}],"predecessor-version":[{"id":28445,"href":"https:\/\/piumedical.com\/en\/wp-json\/wp\/v2\/pages\/27777\/revisions\/28445"}],"wp:attachment":[{"href":"https:\/\/piumedical.com\/en\/wp-json\/wp\/v2\/media?parent=27777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}